ISID Home
about ISID | membership | programs | publications | resources | 14th ICID | site map
 
ProMed Home
  
  Search Criteria |    Display Report |    Search Help 
 
  Navigation
Home
Subscribe/Unsubscribe
Search Archives
Announcements
Recalls/Alerts
Calendar of Events
Maps of Outbreaks
Submit Info
FAQs
Who's Who
Awards
Citing ProMED-mail
Links
Donations
About ProMED-mail
 
Archive Number 20090630.2359
Published Date 30-JUN-2009
Subject PRO/AH/EDR> Influenza A (H1N1) - worldwide (78): Tamiflu resistance, DK
INFLUENZA A (H1N1) - WORLDWIDE (78): TAMIFLU RESISTANCE, DENMARK
****************************************************************
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org>

Date: Mon 29 Jun 2009
Source: BBC News [edited]
<http://news.bbc.co.uk/1/hi/health/8124987.stm>


Experts have reported the 1st case of swine flu that is resistant to 
Tamiflu [oseltamivir], the main drug being used to fight the pandemic. 
Roche Holding AG confirmed a patient with H1N1 influenza in Denmark showed 
resistance to the antiviral drug. David Reddy, company executive, said it 
was not unexpected given that common seasonal flu could do the same.

The news comes as a 9 year old girl has become the 3rd to die in the UK 
with swine flu. It is understood from her doctors at Birmingham Children's 
Hospital that she had underlying health conditions. It is not yet known 
whether swine flu contributed to her death.

Meanwhile, the Department of Health has announced a big jump in the number 
of patients in England confirmed with swine flu, up 1604 since Friday [26 
Jun 2009], taking the UK total so far to 5937. A Health Protection Agency 
spokeswoman stated that: "Routine sampling in the UK has shown that there 
is currently no resistance to oseltamivir or zanamivir." Experts have been 
using Tamiflu, also known as oseltamivir, in a bid to stop the H1N1 
spreading in communities. If taken early, it ensures that symptoms are mild 
and reduces the chance of a victim giving the illness to someone else.

This 1st reported case of resistance developed in a swine flu patient 
taking Tamiflu. Mr Reddy stressed that there were no signs of a 
Tamiflu-resistant strain of H1N1 circulating in the community. This is in 
contrast to seasonal H1N1 flu, where a Tamiflu resistant strain emerged 
last year [2009] and is now widely circulating. Experts fear if this were 
to happen, it could render Tamiflu ineffective [in treatment of the swine 
flu H1N1 virus infection].

Another antiviral drug, called zanamivir or Relenza, made by 
GlaxoSmithKline, is also effective against swine flu. The UK government has 
been stockpiling these antiviral drugs and currently has enough to treat 
half of the population, with a contract to bring that up to 80 per cent as 
soon as possible. Supplies of flu vaccine have also been ordered, and the 
1st doses could be administered in the autumn [2009].

A spokeswoman for the Health Protection Agency said: "The Health Protection 
Agency continues to watch for antiviral resistance and will be carrying out 
regular sample testing throughout this outbreak. We have been monitoring 
antiviral drug resistance since the beginning of this outbreak. Routine 
sampling in the UK has shown that there is currently no resistance to 
oseltamivir or zanamivir." Virologist Professor John Oxford said: "I'm not 
surprised about this finding. The question is whether it is going to 
spread. We will soon know the answer."

-- 
communicated by:
ProMED-mail <promed@promedmail.org>

[According to the European Influenza Surveillance Scheme Weekly Electronic 
Bulletin of 26 Jun 2009 (<http://www.euroflu.org/>), all but one pandemic A(H1N1) viruses tested have been sensitive to oseltamivir and zanamivir but resistant to M2 inhibitors, although widespread (98 per cent) Tamiflu 
resistance has been observed in seasonal A(H1N1) viruses. [see posting Influenza A (H1N1) - worldwide (83): antiviral resistance 20090705.2417] The emergence of Tamiflu-resistant 209 swine-origin A H1N1 influenza virus is not unexpected in view of the widespread and somewhat indiscriminate use of the drug in the treatment of what is still a relatively mild disease. It remains to be seen whether the Tamiflu-resistant virus will spread in Europe and beyond and appear 
independently elsewhere. It is presumed that the Tamiflu-resistant virus 
isolated in Denmark remains sensitive to the alternate neuraminidase 
inhibiter Relenza. - Mod.CP]

[see also:
Influenza A (H1N1) - worldwide (77): case count 20090627.2338
Influenza A (H1N1) - worldwide (76): comments on 1918 virus (03) 20090625.2309
Influenza A (H1N1) - worldwide (74): susp. origin 20090624.2303
Influenza A (H1N1) - worldwide (73): case count, epidemiology 20090622.2288
Influenza A (H1N1) - worldwide (72): case count, epidemiology 20090619.2261
Influenza A (H1N1) - worldwide (70): risk factors 20090619.2260
Influenza A (H1N1) - worldwide (69): other viral infections 20090618.2254
Influenza A (H1N1) - worldwide (68): southern hemisphere 20090618.2253
Influenza A (H1N1) - worldwide (65): antivirals in pregnancy 20090616.2224
Influenza A (H1N1) - worldwide (64): case count, pandemic 20090616.2221
Influenza A (H1N1) - worldwide (62): Egypt, Lebanon 20090611.2150
Influenza A (H1N1) - worldwide (62): Egypt, Lebanon 20090611.2150
Influenza A (H1N1) - worldwide (60): Egypt (Cairo) 20090608.2117
Influenza A (H1N1) - worldwide (59): Worldwide 20060608.2117
Influenza A (H1N1) - worldwide (58): USA, Africa 20090607.2109
Influenza A (H1N1) - worldwide (57): Brazil, USA 20090605.2090
Influenza A (H1N1) - worldwide (55) 20090603.2056
Influenza A (H1N1) - worldwide (47): China, epidemiology 20090526.1962
Influenza A (H1N1) - worldwide (45) 20090525.1951
Influenza A (H1N1) - worldwide (42) 20090523.1929
Influenza A (H1N1) - worldwide (39) 20090521.1903
Influenza A (H1N1) - worldwide (37) 20090520.1893
Influenza A (H1N1) - worldwide (34) 20090518.1863
Influenza A (H1N1) - worldwide (31) 20090516.1835
Influenza A (H1N1) - worldwide (29) 20090515.1824
Influenza A (H1N1) - worldwide (26) 20090514.1798
Influenza A (H1N1) - worldwide (23) 20090511.1764
Influenza A (H1N1) - worldwide (21) 20090510.1749
Influenza A (H1N1) - worldwide (19) 20090509.1733
Influenza A (H1N1) - worldwide (17) 20090508.1722
Influenza (H1N1) - worldwide (15) 20090507.1709
Influenza A (H1N1) - worldwide (13) 20090506.1695
Influenza A (H1N1) - worldwide (11): coincident H3N2 variation 20090505.1679
Influenza A (H1N1) - worldwide (09) 20090504.1673
Influenza A (H1N1) - worldwide (07) 20090503.1658
Influenza A (H1N1) - worldwide (05) 20090503.1657
Influenza A (H1N1) - worldwide (03) 20090501.1646
Influenza A (H1N1) - worldwide (02): case counts 20090430.1638
Influenza A (H1N1) - worldwide 20090430.1636
Influenza A (H1N1) "swine flu": worldwide (07), update, pandemic 5 
20090429.1622
Influenza A (H1N1) "swine flu": worldwide (06) 20090429.1614
Influenza A (H1N1) "swine flu": worldwide (05) 20090428.1609
Influenza A (H1N1) "swine flu": worldwide (04) 20090428.1601
Influenza A (H1N1) "swine flu": worldwide (03) 20090428.1600
Influenza A (H1N1) "swine flu": Worldwide (02) 20090427.1586
Influenza A (H1N1) "swine flu": Worldwide 20090427.1583
Influenza A (H1N1) virus, human: worldwide 20090426.1577
Influenza A (H1N1) virus, human - New Zealand, susp 20090426.1574
Influenza A (H1N1) virus, human - N America (04) 20090426.1569
Influenza A (H1N1) virus, human - N America (03) 20090426.1566
Influenza A (H1N1) virus, human - N America (02) 20090425.1557
Influenza A (H1N1) virus, human - N America 20090425.1552
Acute respiratory disease - Mexico, swine virus susp 20090424.1546
Influenza A (H1N1) virus, swine, human - USA (02): (CA, TX) 20090424.1541
Influenza A (H1N1) virus, swine, human - USA: (CA) 20090422.1516
Influenza A (H1N1) virus, swine, human - Spain 20090220.0715]

...................cp/msp/sh


*##########################################################*
************************************************************
ProMED-mail makes every effort to  verify  the reports  that
are  posted,  but  the  accuracy  and  completeness  of  the
information,   and  of  any  statements  or  opinions  based
thereon, are not guaranteed. The reader assumes all risks in
using information posted or archived by  ProMED-mail.   ISID
and  its  associated  service  providers  shall not be  held
responsible for errors or omissions or  held liable for  any
damages incurred as a result of use or reliance upon  posted
or archived material.
************************************************************
Become     a    ProMED-mail    Premium     Subscriber     at
<http://www.isid.org/ProMEDMail_Premium.shtml>
************************************************************
Visit ProMED-mail's web site at <http://www.promedmail.org>.
Send  all  items  for   posting  to:   promed@promedmail.org

(NOT to  an  individual moderator).  If you do not give your
full name and  affiliation, it  may  not  be  posted.   Send
commands  to  subscribe/unsubscribe,   get  archives,  help,
etc. to: majordomo@promedmail.org.    For assistance  from a
human  being  send  mail  to:   owner-promed@promedmail.org.

############################################################
############################################################

about ISID | membership | programs | publications | resources
14th ICID | site map | ISID home

©2001,2009 International Society for Infectious Diseases
All Rights Reserved.
Read our privacy guidelines.
Use of this web site and related services is governed by the Terms of Service.